-
3 Buses and Auto Components Maker, Agrochemicals and Custom Manufacturing Company and Pharmaceutical Company Stocks With a Strong Future Roadmap: JBM Auto, PI Industries and Natco Pharma
- November 10, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
No Comments
Bus Part, Agrochemical and Pharma Stocks with a strong future roadmap: JBM Auto, PI Industries and Natco Pharma. Compare price, valuation, return on equity and revenue growth as of 9 November 2026.
-
3 Hotel Owner and Operator, Explosives and Defence Products Maker and Specialty Pharma Company Stocks With a Strong Future Roadmap: SAMHI Hotels, Solar Industries India and Natco Pharma
- November 6, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Hotel, Explosives and Oncology Pharma Stocks with a strong future roadmap: SAMHI Hotels, Solar Industries India and Natco Pharma. Compare price, valuation, return on equity and revenue growth as of 5 November 2026.
-
3 Complex Generics and Oncology Drug Maker, Ready to Eat Indian Meals Maker and Decorative Auto Parts Maker Stocks With a Strong Future Roadmap: Natco Pharma, ADF Foods and SJS Enterprises
- November 5, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Cancer Drug, Ready Meal and Vehicle Part Stocks with a strong future roadmap: Natco Pharma, ADF Foods and SJS Enterprises. Compare price, valuation, return on equity and revenue growth as of 4 November 2026.
-
3 India’s Largest Pharma Company, Complex Generics and Oncology Specialist and Branded Generics Maker Stocks With a Strong Future Roadmap: Sun Pharma, Natco Pharma and Lincoln Pharmaceuticals
- October 30, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Branded Generic and Oncology Drug Stocks with a strong future roadmap: Sun Pharma, Natco Pharma and Lincoln Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 28 October 2026.
-
3 Complex Generics and Oncology Company, Fermentation Ingredients Maker and Global Pharma Group Stocks With a Strong Future Roadmap: Natco Pharma, Concord Biotech and Lupin
- October 29, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Oncology, Fermentation and Global Pharma with a strong future roadmap: Natco Pharma, Concord Biotech and Lupin. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Complex Generics and Oncology Company, Active Ingredients Specialist and Contract Formulations Maker Stocks With a Strong Future Roadmap: Natco Pharma, Neuland Laboratories and Innova Captab
- October 28, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Oncology, Ingredient and Contract Pharma with a strong future roadmap: Natco Pharma, Neuland Laboratories and Innova Captab. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Specialty Generics and Branded Formulations Maker, Domestic Brands Specialist and Oncology Focused Drug Maker Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, JB Chemicals and Pharmaceuticals and Natco Pharma
- October 28, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Specialty and Complex Generics Pharma Stocks with a strong future roadmap: Alembic Pharmaceuticals, JB Chemicals and Pharmaceuticals and Natco Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Latin America Branded Generics Seller, Over-the-Counter Formulations Exporter and Oncology and Complex Generics Maker Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Marksans Pharma and Natco Pharma
- October 27, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Emerging Market, OTC and Cancer Drug Stocks with a strong future roadmap: Caplin Point Laboratories, Marksans Pharma and Natco Pharma. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.
-
3 Complex Generics and Oncology Specialist, Global Generics Major and Cardiovascular and Gastro Brands Leader Stocks With a Strong Future Roadmap: Natco Pharma, Dr. Reddy’s Laboratories and Torrent Pharmaceuticals
- October 26, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Oncology, Global Generic and Heart Pharma Stocks with a strong future roadmap: Natco Pharma, Dr. Reddy’s Laboratories and Torrent Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Oncology Specialist, Respiratory and Global Generics Leader and Active Ingredients Maker Stocks With a Strong Future Roadmap: Natco Pharma, Cipla and Granules India
- October 26, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Oncology, Respiratory and API Pharma Stocks with a strong future roadmap: Natco Pharma, Cipla and Granules India. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
- 1
- 2